The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $495,000 in first-year total cost, median $247,500.
Most frequent study sections
- Special Emphasis Panel[ZDA1 JXR-G (13)]2
Most frequent institutions
- BETH ISRAEL DEACONESS MEDICAL CENTER1
- TEMPLE UNIV OF THE COMMONWEALTH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Novel mechanism by which HIV and cocaine subvert vesicular trafficking1R21DA040353-01 | PRASAD, ANIL | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $261,000 | ZDA1 |
| 2015 | Exosome in Methamphetamine and HIV-associated Neurodegeneration1R21DA040329-01 | LI, JIELIANG | TEMPLE UNIV OF THE COMMONWEALTH, PA | $234,000 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.